HES4

HES4 plays an important role in the development of T-cells, which are a type of white blood cell that are a crucial part of the mammalian immune system. The process of T-cell development starts when a signaling pathway called Notch1 is activated in certain blood precursor cells, known as hematopoietic progenitor cells.

Notch1 activation is crucial for initiating T-cell development while suppressing differentiation into other lineages. While the functions of these genes are well understood in mice, the absence of a mouse ortholog for HES4 has made its role in humans less clear.

When Notch1 is activated, it acts like a switch that encourages these cells to become T-cells instead of other types of blood cells, such as those involved in the immune response or red blood cell formation. HES4 is one of the genes that responds to this activation, helping to guide the cells along the T-cell development path.

Research has shown that HES4 works alongside another gene called HES1. While both genes help suppress the development of other cell types, they do so in different ways. HES1 primarily keeps the cells in a resting state, allowing them to maintain their potential to become T-cells. In contrast, HES4 also supports the early stages of T-cell development but does not prevent the formation of B-cells, another important type of immune cell.^[4]

Together, HES4 and HES1 ensure that as blood precursor cells receive the Notch1 signal, so that they successfully start their journey to becoming T-cells.

Because T-cells play an important role in constantly scrutinizing and destroying tumor cells,^[9] and HES4 is important for the development of T-cells in humans, it has been hypothesised to be an oncogene and has been investigated using human cell lines and mice.

The clinical significance of HES4 in osteosarcoma (OS) is highlighted by its potential as a prognostic biomarker.

Studies using human OS cell lines both in vitro and injecting them into live mice in vivo have confirmed that overexpressing HES4 leads to larger and more aggressive tumors, with a greater tendency to spread to other parts of the body.^[5]

Interestingly, while overexpressing HES4 promotes aggressive tumor behavior by inhibiting the normal bone cell differentiation process, another Notch1 target gene, HES1, has opposing effects, where overexpression has a preventative effect on tumor growth.^[5]